alpha-Thrombin derivatives obtained either by site-specific modification at lysyl residues (phosphopyridoxylated) or by limited trypsinolysis (gamma T-thrombin) were compared to correlate structural modifications with the functional reactivity toward fibrin(ogen) and heparin. alpha-Thrombin phosphopyridoxylated in the absence of heparin (unprotected) showed approximately 2 mol of label incorporated/mol of thrombin, but only 1 mol of label incorporated/mol of proteinase when modified in the presence of added heparin (protected). In contrast to native alpha-thrombin, both phosphopyridoxylated alpha-thrombin derivatives failed to interact with a fibrin monomer-agarose column and had reduced fibrinogen clotting activity, which is very similar t...
Heparin cofactor II (HC) is a plasma serine proteinase inhibitor (serpin) that inhibits alpha-thromb...
The activation of human platelets by alpha-thrombin is mediated in part by cleavage of the protease-...
We have recently identified in two unrelated patients with bleeding tendency a homozygous mutation c...
We determined the role of specific thrombin "exosites" in the mechanism of inhibition by the plasma ...
We determined the role of specific thrombin "exosites" in the mechanism of inhibition by the plasma ...
We have recently identified in two unrelated patients with bleeding tendency a homozygous mutation c...
We have examined the interaction of thrombin with fibrinogen A alpha chain residues 7-16. Using gene...
We have examined the interaction of thrombin with fibrinogen A alpha chain residues 7-16. Using gene...
Previous studies from several laboratories have shown that thrombin is inactivated by tetranitrometh...
Previous studies from several laboratories have shown that thrombin is inactivated by tetranitrometh...
Thrombin is the terminal protease in the coagulation cascade and plays a pivotal role in haemostasis...
Thrombin is the terminal protease in the coagulation cascade and plays a pivotal role in haemostasis...
Heparin cofactor II (HCII) is presumed to be a physiological inhibitor of the serine proteinase thro...
Heparin cofactor II (HCII) is presumed to be a physiological inhibitor of the serine proteinase thro...
A peptide containing residues 1-50 of the Aalpha-chain of fibrinogen, expressed as a fusion peptide ...
Heparin cofactor II (HC) is a plasma serine proteinase inhibitor (serpin) that inhibits alpha-thromb...
The activation of human platelets by alpha-thrombin is mediated in part by cleavage of the protease-...
We have recently identified in two unrelated patients with bleeding tendency a homozygous mutation c...
We determined the role of specific thrombin "exosites" in the mechanism of inhibition by the plasma ...
We determined the role of specific thrombin "exosites" in the mechanism of inhibition by the plasma ...
We have recently identified in two unrelated patients with bleeding tendency a homozygous mutation c...
We have examined the interaction of thrombin with fibrinogen A alpha chain residues 7-16. Using gene...
We have examined the interaction of thrombin with fibrinogen A alpha chain residues 7-16. Using gene...
Previous studies from several laboratories have shown that thrombin is inactivated by tetranitrometh...
Previous studies from several laboratories have shown that thrombin is inactivated by tetranitrometh...
Thrombin is the terminal protease in the coagulation cascade and plays a pivotal role in haemostasis...
Thrombin is the terminal protease in the coagulation cascade and plays a pivotal role in haemostasis...
Heparin cofactor II (HCII) is presumed to be a physiological inhibitor of the serine proteinase thro...
Heparin cofactor II (HCII) is presumed to be a physiological inhibitor of the serine proteinase thro...
A peptide containing residues 1-50 of the Aalpha-chain of fibrinogen, expressed as a fusion peptide ...
Heparin cofactor II (HC) is a plasma serine proteinase inhibitor (serpin) that inhibits alpha-thromb...
The activation of human platelets by alpha-thrombin is mediated in part by cleavage of the protease-...
We have recently identified in two unrelated patients with bleeding tendency a homozygous mutation c...